Why the study?
Is the implantation of a miniature wireless pulmonary artery pressure monitoring device safe and feasible in patients with NYHA class III-IV chronic heart failure?
Population
31 patients with chronic heart failure (CHF) in New York Heart Association (NYHA) class III-IV.
Design
Cohort
Follow-up
6 months
Authors
Loading...
Supports wireless PA monitoring safety and compliance in severe HF; hypothesis-generating for outcome benefits in RCTs.
Is the implantation of a miniature wireless pulmonary artery pressure monitoring device safe and feasible in patients with NYHA class III-IV chronic heart failure?
A miniature wireless pulmonary artery pressure monitoring device is safe and feasible for home monitoring in patients with severe chronic heart failure.
Hoppe et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: